|Bid||2.1500 x 1300|
|Ask||2.2900 x 1000|
|Day's Range||2.1500 - 2.2886|
|52 Week Range||1.6800 - 5.3900|
|Beta (5Y Monthly)||1.11|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb. 28, 2022 - Mar. 04, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||10.00|
Here is how Opexa Therapeutics, Inc. (ACER) and Aptinyx Inc. (APTX) have performed compared to their sector so far this year.
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
NEWTON, Mass., Dec. 22, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced that Acer’s management team will participate in the upcoming 11th Annual LifeSci Partners Corporate Access virtual event and the H.C. Wainwright BioConnect Virtual Conference. Conference:11th Annual LifeSci Part